Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Double-blind randomized vehicle- and reference-controlled phase 3 trial of topical potassium permanganate 0.001% for antibacterial efficacy on skin
2004-003740-22Phase 3Completed
- Sponsor
- Pharmazeutische Kontroll- und Herstellungslabor
- Start
- Jan 2005
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of potassium permanganate in skin microbiome (3 arms), sponsored by Pharmazeutische Kontroll- und Herstellungslabor. Primary endpoint: Reduction in number of bacterial colonies on skin. Started Jan 2005; status: completed.
02
Drugs
potassium permanganate
03
Conditions
skin microbiome
Beyond the preview
Go deeper on 2004-003740-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-003740-22.